Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans by Stegenga, M E et al.
 
© 2008 The Authors.
Journal compilation © 2008 Diabetes UK. 
 
Diabetic Medicine
 
,
 
 
 
25
 
, 157–164
 
157
 
DIABETIC
 
Medicine
DOI: 10.1111/j.1464-5491.2007.02348.x
 
Blackwell Publishing Ltd
 
Original Article: Treatment
 
Original article
 
Effect of acute hyperglycaemia and/or hyperinsulinaemia 
on proinflammatory gene expression, cytokine 
production and neutrophil function in humans
 
M. E. Stegenga*†, S. N. van der Crabben‡, M. C. Dessing*†, J. M. Pater*†, 
P. S. van den Pangaart*†, A. F. de Vos*†, M. W. Tanck§, D. Roos¶, H. P. Sauerwein‡ 
and T. van der Poll*†
 
*Centre for Infection and Immunity Amsterdam (CINIMA), †Centre for Experimental and Molecular Medicine, ‡Department of Endocrinology and Metabolism, 
§Department of Clinical Epidemiology and Biostatistics, ¶Sanquin Research, Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, 
Amsterdam, the Netherlands
 
Accepted 7 September 2007
 
Abstract
 
Aims
 
Type 2 diabetes is frequently associated with infectious complications. Swift activation of leucocytes is import-
ant for an adequate immune response. We determined the selective effects of hyperglycaemia and hyperinsulinaemia
on lipopolysaccharide (LPS)-induced proinflammatory gene expression and cytokine production in leucocytes and on
neutrophil functions.
 
Methods
 
Six healthy humans were studied on four occasions for 6 h during: (i) lower insulinaemic euglycaemic clamp,
(ii) lower insulinaemic hyperglycaemic clamp, (iii) hyperinsulinaemic euglycaemic clamp, and (iv) hyperinsulinaemic
hyperglycaemic clamp. Target levels of plasma glucose were 12.0 mmol/l (hyperglycaemic clamps) or 5.0 mmol/l (eugly-
caemic clamps). Target plasma insulin levels were 400 pmol/l (hyperinsulinaemic clamps) or 100 pmol/l (lower insulinae-
mic clamps).
 
Results
 
Hyperglycaemia reduced LPS-induced mRNA expression of nuclear factor of 
 
κ
 
 light polypeptide gene enhancer
in B cells inhibitor alpha (
 
NFKBIA
 
), interleukin-1 alpha (
 
IL1A
 
) and chemokine (C-C motif) ligand 3 (
 
CCL3
 
), whereas
during hyperinsulinaemia enhanced mRNA levels occurred in six out of eight measured inflammation-related genes, irre-
spective of plasma glucose levels. Combined hyperglycaemia and hyperinsulinaemia led to enhanced 
 
IL1A
 
, interleukin-1
beta (
 
IL1B
 
) and 
 
CCL3
 
 mRNA levels upon LPS stimulation. Neither hyperglycaemia nor hyperinsulinaemia altered
cytokine protein production, neutrophil migration, phagocytic capacity or oxidative burst activity.
 
Conclusions
 
These results suggest that short-term hyperglycaemia and hyperinsulinaemia influence the expression of
several inflammatory genes in an opposite direction, that the acute effects of hyperinsulinaemia on inflammatory mRNA
levels may be stronger than those of hyperglycaemia, and that the effects of insulin, in particular, may be relevant in the
concurrent presence of hyperglycaemia.
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Introduction
 
Infection is a common and serious complication of diabetes
mellitus and a well-recognized cause of morbidity and mortality
[1–3]. It has been estimated that infections account for up to
22% of deaths of patients with diabetes. One explanation for
this increased sensitivity to infections may be an impaired
innate immune response in diabetic patients. Both elevated
plasma glucose and insulin, common features of Type 2 dia-
betes, influence the immune system [4,5]. Neutrophils play an
important role during the early host response to infection by a
coordinated series of effector functions that include chemotaxis,
phagocytosis and the generation of reactive oxygen species
(respiratory burst). Neutrophil chemotaxis is hampered in
diabetic patients [6,7]. In one study, hyperglycaemia accounted
for this impairment [8], although another study has shown no
correlation between chemotaxis and glycaemic levels in dia-
betic patients [9]. In addition, neutrophil phagocytic capacity
of diabetic patients was reduced in some [7,10] but not all
investigations [9,11]. Further, all studies [12–16] except one
[17] have shown that hyperglycaemia decreases the respiratory
burst capacity of neutrophils.
In addition to neutrophil functions, the production of cyto-
kines may also be altered by the presence of hyperglycaemia and/
or hyperinsulinaemia. Diabetic patients have displayed elevated
resting levels of tumour necrosis factor (TNF)-
 
α
 
, interleukin
(IL)-6 and IL-8 [18–20]; however, effects of glucose and insulin
on lipopolysaccharide (LPS)-induced proinflammatory cytokine
responses 
 
in vitro
 
 and 
 
in vivo
 
 are contradictory [21–25].
Hyperglycaemia up-regulated the expression of several pro-
inflammatory genes, including those encoding for IL-1
 
β
 
 and
TNF-
 
α
 
 
 
in vitro
 
 [26], the latter gene via increased recruitment of
nuclear factor kappa B (NF-
 
κ
 
B) p65 to the TNF-
 
α
 
 promoter. These
results have been confirmed in a porcine model of diabetes [27].
Studies of the effect of hyperglycaemia and hyperinsulinaemia
on neutrophil functions and proinflammatory gene expression
in Type 2 diabetic patients do not provide insight into the
distinct effects of elevated glucose and insulin concentrations,
since both are present at the same time. Moreover, diabetic
patients almost invariably have other metabolic disturbances
such as dyslipidaemia and increased levels of advanced
glycation end-products. In addition, to our knowledge no
studies in humans have investigated separate hyperglycaemia
without hyperinsulinaemia, as experimental glucose infusion
will induce rapid production of insulin. Therefore, we sought to
determine the distinct effects of short-term hyperinsulinaemia
and/or hyperglycaemia on inflammatory mRNA levels and
neutrophil functions in healthy human volunteers.
 
Methods
 
Subjects and design
 
The present study was performed by an investigation that deter-
mined simultaneously the effects of short-term hyperglycaemia
and/or hyperinsulinaemia on coagulation and fibrinolysis. The
results of that previous study have been published elsewhere
[28]. In brief, six healthy, non-smoking, male volunteers [age
(mean 
 
±
 
 
 
SEM
 
) 21.7 
 
±
 
  0.5  years; weight 73.2 
 
±
 
 2.0 kg;  body
mass index 21.8 
 
±
 
 0.4 kg/m
 
2
 
] were studied. All volunteers
had normal plasma values of fasting glucose and insulin, and
all had a normal oral glucose tolerance test. The study was
approved by the Medical Ethical Committee of the Academic
Medical Centre in Amsterdam and all subjects gave written
informed consent. The study had a cross-over design, with a
wash-out period of 4 weeks, and was done in balanced assign-
ment. Each volunteer served as his own control and was studied
on four occasions, during a lower insulinaemic euglycaemic
(L
 
insu
 
E
 
gluc
 
) clamp (target insulin level 100 pmol/l, target glu-
cose level 5.0 mmol/l), a lower insulinaemic hyperglycaemic
(L
 
insu
 
H
 
gluc
 
) clamp (insulin 100 pmol/l, glucose 12.0 mmol/l), a
hyperinsulinaemic euglycaemic (H
 
insu
 
E
 
gluc
 
) clamp (insulin
400  pmol/l, glucose 5.0  mmol/l) and a hyperinsulinaemic
hyperglycaemic (H
 
insu
 
H
 
gluc
 
) clamp (insulin 400 pmol/l, glucose
12.0 mmol/l). After an overnight fast the subjects were admit-
ted to the clinical research unit and confined to bed. At 08.45 h
a catheter was placed into an antecubital vein for infusion
of insulin, somatostatin, glucagon and glucose 10 or 20%.
Another catheter was inserted retrogradely into a contralateral
hand vein kept in a thermoregulated (60
 
°
 
C) Plexiglas box
for sampling of arterialized venous blood. At 
 
T
 
 
 
=
 
 0 (09.00 h),
infusions of somatostatin (250 
 
μ
 
g/h; Somatostatine-ucb; UCB
Pharma BV, Breda, the Netherlands) to suppress endogenous
insulin and glucagon secretion, and glucagon (1 ng kg
 
–1
 
 min
 
–1
 
;
Glucagen, Novo Nordisk, Alphen a/d Rijn, the Netherlands)
to replace endogenous glucagon concentrations were started;
concurrently infusions of insulin (Actrapid; Novo Nordisk) at
a rate of 10 or 40 mU/m
 
2
 
 body surface area per min (lower or
hyperinsulinaemic clamp, respectively) and glucose 10 or 20%
at a variable rate to obtain eu- or hyperglycaemia were started.
Glucose 20% was used during the L
 
insu
 
E
 
gluc
 
 clamp; in the other
clamps glucose 10% was used to prevent the possibility of
phlebitis induced by the high infusion rates required. All
infusions were administered by calibrated syringe pumps
(Perfusor fm; Braun, Melsungen AG, Germany). To clamp
glucose at 5.0 or 12.0 mmol/l (eu- or hyperglycaemic) from
 
T
 
 
 
=
 
 0:00 until 
 
T
 
 
 
=
 
 6:00, every 5 min the bedside plasma glucose
concentration was measured on a Beckman glucose analyser
2 (Beckman, Palo Alto, CA, USA). At 
 
T
 
 
 
=
 
 0:00, 
 
T
 
 
 
=
 
 3:00 and
from 
 
T
 
 
 
=
 
 5:40 until 
 
T
 
 
 
=
 
 6:00 every 10 min blood samples
were drawn for determination of the concentration of plasma
insulin.
 
Blood collection
 
Blood was collected directly before the initiation of the infu-
sions (
 
T
 
 
 
=
 
 0) and at the end of the infusions (
 
T
 
 
 
=
 
 6). Leucocyte
counts and differentials were determined in ethylenediamine
tetraaceticacid (EDTA)-anticoagulated blood using a Stekker
analyser (counter STKS; Coulter Counter, High Wycombe, UK).
Heparin-anticoagulated blood was used for all other assays.
Plasma insulin concentrations were determined with a chemilu-
minescent immunometric assay (Immulite 2000; Diagnostic
Products Corp., Los Angeles, CA, USA).
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Whole blood stimulation and determination of 
mRNA expression
 
In order to study whole-blood mRNA levels of inflammatory
genes, we chose to do so after LPS stimulation, because non-
stimulated whole blood yields very low or undetectable levels of
mRNA for inflammatory genes (own unpublished observations).
Heparinized whole blood (1 ml) was diluted with an equal volume
of RPMI-1640 (GibcoBRL, Invitrogen, Breda, the Netherlands)
or RPMI-1640 containing LPS (from 
 
Escherichia coli
 
 O111:B4;
Sigma, St Louis, MO, USA) in a final concentration of 10 ng/ml
and incubated in polypropylene tubes for 2 h at 37
 
°
 
C. RNA
isolation and the mRNA expression of nuclear factor of kappa
light polypeptide gene enhancer in B cells 1 (p105; gene symbol
 
NFKB1
 
), nuclear factor of kappa light polypeptide gene enhancer
in B cells inhibitor, alpha (
 
NFKBIA
 
), IL-1 alpha (
 
IL1A
 
), IL-1 beta
(
 
IL1B
 
), TNF-
 
α
 
 (
 
TNF
 
), IL-6 (
 
IL6
 
), IL-8 (
 
IL8
 
) and chemokine
(C-C motif) ligand 3 (
 
CCL3
 
) were determined using the multi-
plex ligation-dependent probe amplification method exactly as
described previously [29–31]. All samples were tested with the
same batch of reagents. The levels of mRNA for each gene were
expressed as a normalized ratio of the peak area divided by the
peak area of the 
 
β
 
2
 
-microglobulin gene (
 
B2M
 
), resulting in relative
abundance of mRNAs of the genes of interest [29–31].
 
Cytokine production
 
Whole blood was stimulated exactly as described above, except
that all samples were stimulated for 24 h. Protein concentrations
of TNF-
 
α
 
, IL-1
 
β
 
, IL-6 and IL-8 were measured in supernatants
by cytometric beads array multiplex assay (BD Biosciences, San
Jose, CA, USA).
 
Neutrophil migration assay
 
Erythrocytes of heparinized whole blood were lysed with an ice-
cold lysis buffer containing 155 m
 
M
 
 NH
 
4
 
Cl, 10 m
 
M
 
 KHCO
 
3
 
and 0.1 m
 
M
 
 EDTA (pH 7.4). Leucocytes were resuspended at
5 
 
×
 
 10
 
6
 
/ml, incubated with 4 
 
μ
 
g/ml Calcein-AM (Molecular
Probes, Eugene, OR, USA) for 30 min at 37
 
°
 
C and washed with
phosphate-buffered saline (PBS), after which they were resus-
pended at 2 
 
×
 
 10
 
6
 
/ml. The chemoattractants complement factor
5a (C5a) and platelet-activating factor (PAF; both from Sigma)
were both prepared in HEPES buffer at concentrations of 10 n
 
M
 
and 100 n
 
M
 
, respectively. A 24-well plate (Multiwell; Becton
Dickinson, Le Pont De Claix, France) was prefilled with 800 
 
μ
 
l
of these chemoattractant solutions or HEPES buffer without
chemoattractant. One well was filled with 800 
 
μ
 
l of cell suspen-
sion. The plate was preheated at 37
 
°
 
C for 5 min. Transwell inserts
with a pore size of 3.0 
 
μ
 
m (HTS Fluoroblok; Becton Dickinson)
were filled with 300 
 
μ
 
l of calcein-labelled cells and placed into
the Multiwell plate. The plate was placed into a Cytofluor 4000
reader (Applied Biosystems, Foster City, CA, USA). Measurements
were performed in triplicate every 2 min for 46 min, using excita-
tion/emission wavelengths of 485/530 nm. The end-point was
defined as the total cell migration after 46 min and was calculated
as the total extent of fluorescence increase. We also calculated
the maximal migration velocity per min by dividing the maximal
increase in fluorescence observed between two measurements
by two. Both measurements were corrected for the mean fluo-
rescence of 800 
 
μ
 
l of cell suspension, and for the percentage of
neutrophilic granulocytes in the whole blood of the volunteer,
and were calculated either as relative fluorescence units (RFU),
or as delta RFU per min (dRFU/min).
 
Respiratory burst assay
 
Nicotinamide adenine dinucleotide phosphate-oxidase activity
was assessed as hydrogen peroxide release determined by an
Amplex Red kit (Molecular Probes). Neutrophils (0.25 
 
×
 
 10
 
6
 
/ml)
were stimulated with buffer or with 100 ng/ml phorbol 12-
myristate 13-acetate (Sigma), in the presence of Amplex Red
(0.5 
 
μ
 
M
 
) and horseradish peroxidase (1 U/ml), in a black 96-
well plate with a clear bottom (Greiner, Alphen a/d Rijn, the
Netherlands). Fluorescence was measured with a Cytofluor
4000 platereader (Applied Biosystems) using excitation/
emission wavelengths of 530/580  nm. Measurements were
performed in triplicate every min for 35 min. The results were
calculated as the maximal increase in fluorescence per min. The
results were corrected for the percentage of neutrophilic granu-
locytes in the whole blood of the volunteer and for the negative
control, and depicted as increase of RFU per min (dRFU/min).
 
Phagocytosis
 
The uptake of 
 
E. coli
 
 by neutrophils was analysed essentially as
described previously [32,33]. Heat-killed 
 
E. coli
 
 were labelled
with fluorescein isothiocyanate (Sigma-Aldrich, St Louis, MO,
USA) and added to 100 
 
μ
 
l of heparinized whole blood (bacterium/
neutrophil ratio of 25 : 1). Bacteria and cells were incubated
for 12 min at 37
 
°
 
C and also at 4
 
°
 
C as a negative control.
Phagocytosis was stopped by immediately transferring the
cells to 4
 
°
 
C and washing them with ice-cold FACS buffer (PBS
supplemented with 0.01% NaN
 
3
 
, 0.5% bovine serum albumin
and 0.35 m
 
M
 
 EDTA). The cells were treated with vital blue stain
(Orpegen, Heidelberg, Germany) to quench extracellular fluo-
rescence, washed with FACS buffer and analysed using a FACS
Calibur flow cytometer (Becton Dickinson, Mountain View,
CA, USA). Neutrophils were gated based on forward and side
scatter. Results are expressed as phagocytosis index, defined as
the percentage of cells with internalized 
 
E. coli
 
 times the mean
fluorescence intensity (corrected for the negative controls).
 
Statistical analysis
 
To analyse the effect of hyperinsulinaemia and/or hypergly-
caemia and their interaction, results of the four clamps were
compared using a repeated measures analysis of variance (repeated
covariance type: compound symmetry). Data were checked
for normal distribution and equal variances of the residuals.
Depending on the results of these tests, data were analysed
either parametrically or non-parametrically (rank-transformed
data) [34]. Results are presented as percentage change relative
to 
 
T
 
 
 
=
 
 0 as mean (
 
±
 
 
 
SEM
 
). Probability values of 
 
<
 
 0.05 were con-
sidered statistically significant. Probability values of overall in-
sulin, glucose and interaction effects are stated as 
 
P
 
insu
 
, 
 
P
 
gluc
 
 and
 
P
 
interaction
 
, respectively. SPSS statistical software version 12.0.1
(SPSS Inc., Chicago, IL, USA) was used to analyse the data.
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Results
 
Glucose and insulin
 
Glucose and insulin levels during the four clamps have been
reported previously [28].
 
White blood cell count and differentiation
 
During all clamps a small but statistically significant decrease
in total leucocyte counts occurred, which was primarily caused
by a small decrease in neutrophil counts (
 
P
 
 
 
<
 
 0.05 in all four
clamps, Table 1). Importantly, leucocyte counts and different-
ials did not differ between the four clamps, with the exception
of lymphocyte counts, which were slightly but statistically
significantly lower at the end of the H
 
insuHgluc clamp.
Proinflammatory gene expression
Whole blood that was incubated with control medium yielded
very low or undetectable mRNA levels at both T = 0 and 6 h
(data not shown). As expected, LPS stimulation of blood
leucocytes of all subjects at T = 0 h (Table 2) and 6 h (data not
shown) induced strong up-regulation of NFKB1, NFKBIA,
IL1A, IL1B, TNF, IL6, IL8 and CCL3 expression. To deter-
mine the effect of hyperglycaemia and/or hyperinsulinaemia
on leucocyte responsiveness to LPS, we expressed the extent
of LPS-induced up-regulation of various genes at T = 6 h as a
percentage of the extent of LPS-induced up-regulation at T = 0 h
for each individual. Considering that each volunteer was studied
in all four clamps, the changes in LPS-induced gene expression
as measured at the end of each clamp (T = 6 h) were then
compared for each individual (Fig. 1). The extent of proinflam-
matory gene expression did not change during the LinsuEgluc
clamp. Hyperglycaemia and hyperinsulinaemia had distinct
effects on LPS-induced proinflammatory gene expression.
Hyperglycaemia per se (in the absence of hyperinsulinaemia)
in general resulted in attenuated LPS-induced gene expression
when compared with the other three clamps; in particular, the
expression of NFKB1 (P = 0.09), NFKBIA, IL1A and CCL3
(all  P <  0.05) decreased when compared with the LinsuEgluc
clamp. In contrast, hyperinsulinaemia enhanced LPS-induced
gene expression of several cytokine genes, and its effect on
mRNA induction of IL1A, IL1B and CCL3 was especially
clear in the concurrent presence of hyperglycaemia. To check
for an overall insulin effect, LPS-induced gene expression at
the end of the lower insulinaemic clamps was compared with
gene expression at the end of both high insulinaemic clamps.
Hyperinsulinaemia in either the presence or the absence of hyper-
glycaemia induced enhanced mRNA levels of all measured
genes (Pinsu < 0.05), except for NFKB1 (Pinsu = 0.09) and
TNF (Pinsu = 0.16). Thus, hyperinsulinaemia enhanced levels
of several inflammation-related genes, and this effect was irre-
spective of simultaneous glucose levels for NFKBIA, IL1B,
IL6 and IL8. We did not find an overall glucose effect on LPS-
stimulated whole blood mRNA (Pgluc > 0.05 for all measured
genes). Finally, there was a significant interaction between
Table 1 Leucocyte counts and differentials
Cell subset (106/ml)
LinsuEgluc HinsuEgluc LinsuHgluc HinsuHgluc
T = 0 T = 6 T = 0 T = 6 T = 0 T = 6 T = 0 T = 6
Leucocytes 5.3 ± 0.6 4.2 ± 0.3* 4.9 ± 0.3 4.0 ± 0.2* 6.0 ± 0.5 4.8 ± 0.4* 5.3 ± 0.5 4.0 ± 0.5*
Neutrophils 2.9 ± 0.6 1.8 ± 0.2* 2.5 ± 0.3 1.8 ± 0.2* 3.5 ± 0.4 2.4 ± 0.2* 2.9 ± 0.3 2.0 ± 0.4*
Lymphocytes 1.7 ± 0.2 1.8 ± 0.2 1.7 ± 0.2 1.6 ± 0.1 1.7 ± 0.2 1.7 ± 0.2 1.7 ± 0.1 1.5 ± 0.1*,**
Monocytes 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.4 ± 0.0 0.5 ± 0.1 0.4 ± 0.0 0.5 ± 0.1 0.4 ± 0.1*
Absolute leucocyte and subset counts at T = 0 and T = 6 h, i.e. the time points at which proinflammatory gene expression and neutrophil 
functions were investigated. Results are shown as mean ± SEM.
*P < 0.05 vs. baseline of clamp; **P < 0.05 vs. LinsuEgluc clamp.
Table 2 LPS-induced inflammatory gene expression in blood leucocytes
mRNA Genbank
Expression (fold over B2M)
Med LPS
NFKB1 M58603 0.19 ± 0.01 0.77 ± 0.07*
NFKBIA NM_020529 0.70 ± 0.09 2.34 ± 0.16*
IL1A X02851 0.30 ± 0.01 1.64 ± 0.10*
IL1B M15330 0.51 ± 0.12 4.78 ± 0.19*
TNF M10988 0.06 ± 0.01 0.51 ± 0.06*
IL6 M14584 0.03 ± 0.01 2.39 ± 0.20*
IL8 M17017 0.61 ± 0.07 2.98 ± 0.25*
CCL3 NM_002983 0.33 ± 0.09 5.97 ± 0.35*
Influence of lipopolysaccharide (LPS) stimulation on whole blood 
mRNA expression profiles. Whole blood drawn from untreated 
volunteers at T = 0 h was incubated for 2 h with either medium 
control (Med) or LPS. mRNA profiles of all samples were 
determined with the multiplex ligation-dependent probe 
amplification method. Values represent relative expression of 
indicated mRNA levels compared with mRNA levels of β2-
microglobulin. Results are shown as mean ± SEM.
*P < 0.0001 vs. negative control. For samples that were below 
detection level (only present in the medium-stimulated group), 
the detection level was used in calculations. Differences between 
medium and LPS stimulation are therefore underestimated.
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hyperglycaemia and hyperinsulinaemia on post-clamp mRNA
levels of IL1A and CCL3 (Pinteraction < 0.05).
Cytokine expression
In a similar way as mRNA expression was analysed, we invest-
igated changes in LPS-induced production of TNF-α, IL-1β,
IL-6 and IL-8 as measured at T = 6 h, for each individual (data
not shown). There was no difference in cytokine production
between any of the four separate clamps (P  >  0.05 for all
cytokines). In addition, we observed no overall effect of
insulin, glucose or interaction of either condition on cytokine
levels (Pinsu, Pgluc and Pinteraction > 0.05 for all cytokines).
Neutrophil functions
We studied three neutrophil functions considered important
for adequate innate immune response to invading bacteria:
migration, respiratory burst and phagocytosis (Fig.  2). All
measurements performed at T = 6 h were expressed as a
percentage of the values measured at T = 0 h, and the changes
in neutrophil functions as measured at the end of each clamp
(T = 6 h) were compared for each individual in the four differ-
ent clamps. Neither hyperglycaemia nor hyperinsulinaemia
per se influenced neutrophil functions. The only effect measured
was increased neutrophil migration toward PAF at the end of
the HinsuHgluc clamp, when compared with the clamps with
FIGURE 1 Influence of hyperinsulinaemia 
and/or hyperglycaemia on proinflammatory 
mRNA levels. Six subjects were studied on four 
separate occasions: during a lower insulinaemic 
euglycaemic (LinsuEgluc) clamp (A), a 
hyperinsulinaemic euglycaemic (HinsuEgluc) 
clamp (B), a lower insulinaemic 
hyperglycaemic (LinsuHgluc) clamp (C) and a 
hyperinsulinaemic hyperglycaemic (HinsuHgluc) 
clamp (D). Whole blood obtained at T = 0 and 
T = 6 h was stimulated for 2 h with 
lipopolysaccharide. White blood cells were 
analysed for mRNA levels relative to mRNA 
levels of the B2M household gene. Data are the 
mean (± SEM) changes in mRNA level ratios at 
the end of the clamps relative to the change 
detected at baseline. *P < 0.05; **P < 0.01 and 
***P < 0.001; †P < 0.05 for interaction of 
hyperglycaemia and hyperinsulinaemia.
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hyperglycaemia or hyperinsulinaemia alone. This effect was
not seen when C5a was used as chemoattractant.
Discussion
In this study we have investigated the acute influence of hyper-
glycaemia and/or hyperinsulinaemia, using 6-h clamps in
healthy humans, on mRNA levels of inflammation-related
genes and neutrophil function assays. In this strictly controlled
setting, in which each subject served as his own control in four
different conditions, hyperglycaemia led to slightly decreased
LPS-stimulated mRNA levels of NFKBIA, IL1A and CCL3
compared with euglycaemia, whereas hyperinsulinaemia
caused increased mRNA levels in the majority of measured
inflammatory genes. Relative to the effect of hyperinsulinaemia
alone, combined hyperglycaemia and hyperinsulinaemia led to
a further increase in IL1A, IL1B and CCL3 mRNA levels. Six
hours of hyperinsulinaemia and/or hyperglycaemia had no
significant effects on cytokine protein production or on crucial
neutrophil functions, although the combined presence of
hyperinsulinaemia and hyperglycaemia enhanced neutrophil
migration when PAF was used as chemoattractant.
The number of studies investigating the role of hyperglycae-
mia or hyperinsulinaemia on inflammatory gene expression is
limited. In monocyte-like THP-1 cells, 72 h of hyperglycaemia
induced gene expression of several cytokines, chemokines and
adhesion molecules [26]. In the same cell line and in human
monocyte-derived macrophages, supraphysiological insulin
concentrations stimulated the production of TNF-α mRNA
and protein [22]. Also in cultured human myotubes, supraphy-
siological doses of insulin induced an inflammatory transcrip-
tional response [35]. These last three studies have examined
the direct effects of either hyperglycaemia or hyperinsulinaemia,
and reported (with the exception of two out of 41 measured
genes [26]) small to moderate increases in proinflammatory
gene expression profiles (from 1.5 to 5 times gene expression
compared with control). Our observation that hyperglycaemia
induced lower mRNA levels of NFKBIA, which encodes the
NF-κB-inhibitor protein ‘inhibitor of kappa-Bα’ (IκBα), is in
line with observations that IκBα protein levels decreased in
healthy humans after an oral glucose load, although in this last
study insulin levels were not suppressed by somatostatin [36].
Despite this, mRNA levels of the proinflammatory genes
IL1A and CCL3 were also lower, and NFKB1 was also not up-
regulated after hyperglycaemia. We do not have an explana-
tion for this apparent distinction. However, the observed
changes in mRNA level were not accompanied by any change
in concentrations of cytokine proteins. The induction of acute
hyperglycaemia in healthy humans elevated circulating levels
of TNF-α and IL-6 [37], although these elevations were very
modest, especially when compared with cytokine increases
observed during inflammatory reactions. Plasma protein levels
of TNF-α and IL-6 in Type 2 diabetic patients are only moder-
ately higher (1.5–2 times the concentration of non-diabetic
control subjects) [38,39]. To examine the effects of hypergly-
caemia and/or hyperinsulinaemia after a proinflammatory
stimulus, we studied gene expression profiles in unfractionated
blood leucocytes during LPS stimulation. We intentionally
chose to examine whole blood leucocytes in order to keep the
cells in their hyperglycaemic and/or hyperinsulinaemic environ-
ment during stimulation and to avoid artificial gene expression
due to procedures to isolate specific cell types. Given that leucocyte
counts were not influenced by the presence of hyperglycaemia
and/or hyperinsulinaemia, it is valid to compare LPS-induced
FIGURE 2 Influence of hyperinsulinaemia and/
or hyperglycaemia on neutrophil migration, 
respiratory burst and phagocytic capacity. Six 
subjects were studied on four separate 
occasions: during a lower insulinaemic 
euglycaemic (LinsuEgluc) clamp (A), a 
hyperinsulinaemic euglycaemic (HinsuEgluc) 
clamp (B), a lower insulinaemic 
hyperglycaemic (LinsuHgluc) clamp (C) and a 
hyperinsulinaemic hyperglycaemic (HinsuHgluc) 
clamp (D). Upper panels: neutrophil migration 
toward platelet-activating factor and 
complement 5a. Lower left panel: respiratory 
burst induced by phorbol 12-myristate 13-
acetate. Lower right panel: phagocytosis of 
Escherichia coli. Data are the mean (± SEM) 
values at the end of the clamps relative to the 
values measured at baseline. *P < 0.05; 
†P < 0.05 for interaction of hyperglycaemia 
and hyperinsulinaemia.
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mRNA expression in the different clamps. Our results show
that 6 h of hyperglycaemia and/or hyperinsulinaemia lead to
changes in LPS-induced expression of some but not all inflam-
matory genes evaluated. Remarkably, hyperglycaemia seemed
to reduce gene expression (significantly so for NFKBIA, IL1A
and CCL3), whereas hyperinsulinaemia enhanced the expression
of six out of eight measured inflammatory genes. The hyper-
insulinaemic effects on gene expression occurred irrespective
of simultaneous plasma glucose concentrations, except for
IL1A and CCL3. This remarkable finding implicates that in
our tightly controlled setting, the effects of hyperinsulinaemia
overrule those observed in hyperglycaemia alone. At the same
time, hyperinsulinaemia enhanced expression of some of these
genes, particularly in the presence of hyperglycaemia. These
results suggest that: short-term hyperglycaemia and hyperin-
sulinaemia influence the expression of several inflammatory
genes in an opposite direction; the acute effect of hyperinsuli-
naemia may be more powerful compared with hyperglycaemia
in vivo on inflammatory mRNA levels; and that the effects of
insulin, in particular, may be relevant in the concurrent pres-
ence of hyperglycaemia. Recently, two studies have examined
the effects of hyperinsulinaemia on LPS-induced cytokine
release in healthy humans in vivo [40,41]. In both studies
hyperinsulinaemia modestly increased LPS-induced IL-6 release
while not influencing TNF-α levels. Other cytokines were not
evaluated in these studies. Of note, the insulin levels achieved
in these studies were much higher (800–1200 pmol/l) than in
our current investigation (around 400 pmol/l).
Type 2 diabetes has been associated with a number of
neutrophil dysfunctions. Most (albeit not all) investigations in
Type 2 diabetic patients have reported reduced neutrophil
migration, phagocytic capacity and respiratory burst [4,7,9–
11]. Our findings strongly argue against an acute effect of
hyperglycaemia and/or hyperinsulinaemia on these neutrophil
functions, which are considered important for antibacterial
defence. Indeed, neither hyperglycaemia nor hyperinsulinaemia
influenced neutrophil migration, respiratory burst activity or
phagocytic capacity, and the combined presence of hypergly-
caemia and hyperinsulinaemia had an enhancing effect (if
any) on neutrophil migration. While our studies were in progress,
Fejfarova et al. also reported a lack of influence of short-term
hyperglycaemia and/or hyperinsulinaemia on neutrophil phago-
cytic and respiratory burst capacity [42]. Together, these findings
suggest that both chronic hyperglycaemia and/or hyperinsuli-
naemia impact on neutrophil functions and/or that other
metabolic disturbances, such as dyslipidaemia or elevated levels
of advanced glycation end-products, affect these functions.
Our study examined the acute effects of hyperglycaemia
and/or hyperinsulinaemia and can therefore not directly be extra-
polated to chronic conditions such as Type 2 diabetes and other
insulin resistance syndromes. However, it is not feasible to
study the chronic effects of isolated hyperglycaemia or isolated
hyperinsulinaemia in healthy humans, in particular when
using a tightly controlled design, such as implemented here.
Instead, this study set-up has the exclusive ability to investigate
two key components of Type 2 diabetes (hyperglycaemia and
hyperinsulinaemia) separately from each other and from other
metabolic disturbances that are part of Type 2 diabetes. We
have shown that acute elevations in plasma glucose and/or
insulin levels lead to alterations in an otherwise normally func-
tioning immune system.
In conclusion, we have demonstrated that short-term hyper-
glycaemia reduced whereas combined hyperglycaemia and
hyperinsulinaemia stimulated several, but not all, proinflam-
matory mRNA levels in blood leucocytes upon stimulation
with LPS. Neither hyperglycaemia nor hyperinsulinaemia acutely
affected cytokine concentrations or neutrophil functions.
Competing interests
M.E.S. received a grant from the Dutch Diabetes Research
foundation (grant no. 2002.00.008). No other competing
interests to declare.
Acknowledgements
The authors thank R. M. E. Blümer, M. T. Ackermans, A. F.
C. Ruiter and B. C. E. Voermans for their indispensable help
during the experiments.
References
1 Smitherman KO, Peacock JE Jr. Infectious emergencies in patients
with diabetes mellitus. Med Clin North Am 1995; 79: 53–77.
2 McMahon MM, Bistrian BR. Host defenses and susceptibility to
infection in patients with diabetes mellitus. Infect Dis Clin North Am
1995; 9: 1–9.
3 Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in
patients with diabetes mellitus. N Engl J Med 1999; 341: 1906–1912.
4 Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate
immune system: clinical, cellular, and molecular aspects. Crit Care
Med 2005; 33: 1624–1633.
5 Krogh-Madsen R, Plomgaard P, Keller P, Keller C, Pedersen BK.
Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene
expression in human subcutaneous adipose tissue. Am J Physiol
Endocrinol Metab 2004; 286: E234–E238.
6 Geerlings SE, Hoepelman AI. Immune dysfunction in patients with
diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:
259–265.
7 Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H,
Genetet B. Impaired leucocyte functions in diabetic patients. Diabet
Med 1997; 14: 29–34.
8 Wierusz-Wysocka B, Wysocki H, Wykretowicz A, Klimas R. The
influence of increasing glucose concentrations on selected functions
of polymorphonuclear neutrophils. Acta Diabetol Lat 1988; 25:
283–288.
9 Tater D, Tepaut B, Bercovici JP, Youinou P. Polymorphonuclear cell
derangements in Type I diabetes. Horm Metab Res 1987; 19: 642–
647.
10 Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of poly-
morphonuclear leukocyte function and metabolic control of diabetes.
Diabetes Care 1992; 15: 256–260.
11 Balasoiu D, van Kessel KC, van Kats-Renaud HJ, Collet TJ,
Hoepelman AI. Granulocyte function in women with diabetes and
asymptomatic bacteriuria. Diabetes Care 1997; 20: 392–395.
dme_2348.fm  Page 163  Tuesday, February 12, 2008  11:07 AMDIABETICMedicine Hyperglycaemia and hyperinsulinaemia and insulin alter immune responses • M. E. Stegenga et al.
© 2008 The Authors.
164 Journal compilation © 2008 Diabetes UK. Diabetic Medicine, 25, 157–164
12 Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG,
MacCuish AC. Neutrophil bactericidal function in diabetes mellitus:
evidence for association with blood glucose control. Diabet Med
1995; 12: 916–920.
13 Nielson CP, Hindson DA. Inhibition of polymorphonuclear leuko-
cyte respiratory burst by elevated glucose concentrations in vitro.
Diabetes 1989; 38: 1031–1035.
14 Oldenborg PA, Sundqvist IM, Sehlin J. Different effects of glucose on
extracellular and intracellular respiratory burst response in normal
human neutrophils activated with the soluble agonist fMet-Leu-Phe.
Diabet Med 2000; 17: 532–537.
15 Ortmeyer J, Mohsenin V. Inhibition of phospholipase D and super-
oxide generation by glucose in diabetic neutrophils. Life Sci 1996;
59: 255–262.
16 Perner A, Nielsen SE, Rask-Madsen J. High glucose impairs super-
oxide production from isolated blood neutrophils. Intensive Care
Med 2003; 29: 642–645.
17  Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona
P. Glucose challenge stimulates reactive oxygen species (ROS)
generation by leucocytes. J Clin Endocrinol Metab 2000; 85:
2970–2973.
18 Mysliwska J, Zorena K, Bakowska A, Skuratowicz-Kubica A,
Mysliwski A. Significance of tumor necrosis factor alpha in patients
with long-standing Type-I diabetes mellitus. Horm Metab Res 1998;
30: 158–161.
19 Pickup JC, Crook MA. Is Type II diabetes mellitus a disease of the
innate immune system? Diabetologia 1998; 41: 1241–1248.
20 Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K, Wierusz-
Wysocka B. Serum interleukin-8 level is increased in diabetic
patients. Diabetologia 1999; 42: 117–118.
21 Orlinska U, Newton RC. Role of glucose in interleukin-1 beta pro-
duction by lipopolysaccharide-activated human monocytes. J Cell
Physiol 1993; 157: 201–208.
22 Iida KT, Shimano H, Kawakami Y, Sone H, Toyoshima H, Suzuki S
et al. Insulin up-regulates tumor necrosis factor-alpha production in
macrophages through an extracellular-regulated kinase-dependent
pathway. J Biol Chem 2001; 276: 32531–32537.
23 Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ.
Human aging is associated with altered TNF-alpha production during
hyperglycemia and hyperinsulinemia. Am J Physiol Endocrinol
Metab 2001; 281: E1137–1143.
24 Satomi N, Sakurai A, Haranaka K. Relationship of hypoglycemia to
tumor necrosis factor production and antitumor activity: role of
glucose, insulin, and macrophages. J Natl Cancer Inst 1985; 74:
1255–1260.
25 Fraker DL, Merino MJ, Norton JA. Reversal of the toxic effects of
cachectin by concurrent insulin administration. Am J Physiol 1989;
256: E725–731.
26 Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-
induced expression of proinflammatory cytokine and chemokine
genes in monocytic cells. Diabetes 2003; 52: 1256–1264.
27 Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL et al.
Diabetes-induced oxidative stress and low-grade inflammation in
porcine coronary arteries. Circulation 2003; 108: 472–478.
28 Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW,
Sauerwein HP et al. Hyperglycemia stimulates coagulation, whereas
hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes
2006; 55: 1807–1812.
29 Spek CA, Verbon A, Aberson H, Pribble JP, McElgunn CJ, Turner T
et al. Treatment with an anti-CD14 monoclonal antibody delays and
inhibits lipopolysaccharide-induced gene expression in humans in
vivo. J Clin Immunol 2003; 23: 132–140.
30 Wettinger SB, Doggen CJ, Spek CA, Rosendaal FR, Reitsma PH.
High throughput mRNA profiling highlights associations between
myocardial infarction and aberrant expression of inflammatory
molecules in blood cells. Blood 2005; 105: 2000–2006.
31 Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM
et al. Antiinflammatory effects of salmeterol after inhalation of
lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med
2005; 172: 878–884.
32 Weijer S, Sewnath ME, de Vos AF, Florquin S, van der Sluis K,
Gouma DJ et al. Interleukin-18 facilitates the early antimicrobial
host response to Escherichia coli peritonitis. Infect Immun 2003; 71:
5488–5497.
33 Wan CP, Park CS, Lau BH. A rapid and simple microfluorometric
phagocytosis assay. J Immunol Methods 1993; 162: 1–7.
34 Conover WJ, Iman RL. Analysis of covariance using the rank trans-
formation. Biometrics 1982; 38: 715–724.
35 Hansen L, Gaster M, Oakeley EJ, Brusgaard K, Damsgaard Nielsen
EM, Beck-Nielsen H et al. Expression profiling of insulin action in
human myotubes: induction of inflammatory and pro-angiogenic
pathways in relationship with glycogen synthesis and Type 2 diabetes.
Biochem Biophys Res Commun 2004; 323: 685–695.
36 Aljada A, Friedman J, Ghanim H, Mohanty P, Hofmeyer D, Chaud-
huri A et al. Glucose ingestion induces an increase in intranuclear
nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an
increase in tumor necrosis factor alpha messenger RNA by mononu-
clear cells in healthy human subjects. Metabolism 2006; 55: 1177–
1185.
37 Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola
M et al. Inflammatory cytokine concentrations are acutely increased
by hyperglycemia in humans: role of oxidative stress. Circulation
2002; 106: 2067–2072.
38 Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6,
tumour necrosis factor alpha and blood cytokine production in Type
2 diabetes. Life Sci 2000; 67: 291–300.
39 Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, Kibata M.
Relationship between serum tumor necrosis factor-alpha and insulin
resistance in obese men with Type 2 diabetes mellitus. Diabetes Res
Clin Pract 2001; 52: 119–123.
40 Krogh-Madsen R, Moller K, Dela F, Kronborg G, Jauffred S,
Pedersen BK. Effect of hyperglycemia and hyperinsulinemia on the
response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in
humans. Am J Physiol Endocrinol Metab 2004; 286: E766–E772.
41 Soop M, Duxbury H, Agwunobi AO, Gibson JM, Hopkins SJ,
Childs C et al. Euglycemic hyperinsulinemia augments the cytokine
and endocrine responses to endotoxin in humans. Am J Physiol
Endocrinol Metab 2002; 282: E1276–1285.
42 Fejfarova V, Jirkovska A, Lupinkova J, Kovar J, Kalanin J, Striz I
et al. Effect of acute hyperglycemia and/or hyperinsulinemia on poly-
morphonuclear functions in healthy subjects. Metabolism 2006; 55:
811–818.
dme_2348.fm  Page 164  Tuesday, February 12, 2008  11:07 AM